For laboratory research only
Conditions of supply
PepC.Labs supplies research compounds for in-vitro laboratory research only. They are not medicines, food, supplements or cosmetics, and are not for human or veterinary consumption. No product is intended to diagnose, treat, cure or prevent any condition.
By entering, I also confirm I will not use these products on people or animals, and I agree to the Terms of Service.
We record your confirmation (time and page) so we can show payment providers our terms were accepted. Asked once a year.
Payment by PayID or bank transfer.
Check the batch details and test results in the certificate.
Published research is separate from the batch test results for this vial.
Browse the research libraryFour-peptide regenerative research blend: GHK-Cu 50mg, BPC-157 10mg, TB-500 10mg, KPV 10mg (80mg total per vial). Studied across collagen synthesis, tissue-repair, angiogenesis and anti-inflammatory models.
Listed Purity
99.00%
Method
HPLC
Certificate
$2.50 / mg
In stock, ships from Sydney
4.9 / 5
Customers rate our packing, speed and replies after every order, never a product. Every rating counts toward the score.
For research use only. Not for human consumption. By purchasing this product, you confirm it will be used solely for legitimate research purposes.
Four-peptide regenerative research blend: GHK-Cu 50mg, BPC-157 10mg, TB-500 10mg, KPV 10mg (80mg total per vial). Studied across collagen synthesis, tissue-repair, angiogenesis and anti-inflammatory models.
KLOW is a combination research blend of four peptides studied for overlapping regenerative and cytoprotective pathways: GHK-Cu (50mg), the copper tripeptide associated in published work with collagen and elastin synthesis, antioxidant activity and broad gene-expression modulation; BPC-157 (10mg), a gastric pentadecapeptide investigated for angiogenesis and tendon, ligament and gut-lining repair in animal models; TB-500 (10mg), a thymosin β-4 fragment studied for actin-cytoskeleton regulation and cell migration in tissue-repair research; and KPV (10mg), the C-terminal α-MSH tripeptide associated with NF-κB pathway inhibition and reduced inflammatory cytokine secretion. The blend is supplied lyophilised, 80mg total per vial. For research use only. Not for human consumption.
